Harmony Biosciences projects flagship drug will hit $1B; ends work on another product

​Harmony Biosciences expects its narcolepsy treatment Wakix to reach a major sales milestone in 2026, but the Plymouth Meeting company has faced recent setbacks with other drugs in its pipeline. 

Read More from Bizjournals.com Feed (2025-02-17 17:26:56)

Leave a Reply

Discover more from ZoomHoot - The Important Information You Need

Subscribe now to keep reading and get access to the full archive.

Continue reading